Intrinsic Value of S&P & Nasdaq Contact Us

Electromed, Inc. ELMD NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
81/100
5/7 Pass
SharesGrow Intrinsic Value
$21.38
-15.2%
Analyst Price Target
$38.00
+50.7%

Electromed, Inc. (ELMD) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 4 Buy.

The consensus price target is $38.00, representing an upside of 50.7% from the current price $25.21.

Analysts estimate Earnings Per Share (EPS) of $0.51 and revenue of $0.06B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $0.60 vs est $0.51 (beat +17.6%). 2025: actual $0.90 vs est $0.82 (beat +10.4%). Analyst accuracy: 88%.

ELMD Stock — 12-Month Price Forecast

$38.00
▲ +50.73% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Electromed, Inc., the price target is $38.00.
The average price target represents a +50.73% change from the last price of $25.21.

ELMD Analyst Ratings

Buy
4
Ratings
4 Buy
Based on 4 analysts giving stock ratings to Electromed, Inc. in the past 3 months
Rating breakdown
Buy
4 100%
100%
Buy
4 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — ELMD

88%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.60 vs Est $0.51 ▲ 15.0% off
2025 Actual $0.90 vs Est $0.82 ▲ 9.4% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving.

Revenue Estimates — ELMD

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.055B vs Est $0.055B ▼ 0.3% off
2025 Actual $0.064B vs Est $0.063B ▲ 1.3% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message